FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1954733039> ?p ?o ?g. }

• W1954733039 endingPage "7014" @default.
• W1954733039 startingPage "7008" @default.
• W1954733039 abstract "We investigated the role of nitric oxide (NO) in inflammatory hyperalgesia. Coinjection of prostaglandin E2 (PGE2) with the nitric oxide synthase (NOS) inhibitor NG-methyl-L-arginine (L-NMA) inhibited PGE2-induced hyperalgesia. L-NMA was also able to reverse that hyperalgesia. This suggests that NO contributes to the maintenance of, as well as to the induction of, PGE2-induced hyperalgesia. Consistent with the hypothesis that the NO that contributes to PGE2-induced sensitization of primary afferents is generated in the dorsal root ganglion (DRG) neurons themselves, L-NMA also inhibited the PGE2-induced increase in tetrodotoxin-resistant sodium current in patch-clamp electrophysiological studies of small diameter DRG neurons in vitro. Although NO, the product of NOS, often activates guanylyl cyclase, we found that PGE2-induced hyperalgesia was not inhibited by coinjection of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), a guanylyl cyclase inhibitor. We then tested whether the effect of NO depended on interaction with the adenylyl cyclase-protein kinase A (PKA) pathway, which is known to mediate PGE2-induced hyperalgesia. L-NMA inhibited hyperalgesia produced by 8-bromo-cAMP (a stable membrane permeable analog of cAMP) or by forskolin (an adenylyl cyclase activator). However, L-NMA did not inhibit hyperalgesia produced by injection of the catalytic subunit of PKA. Therefore, the contribution of NO to PGE2-induced hyperalgesia may occur in the cAMP second messenger pathway at a point before the action of PKA. We next performed experiments to test whether administration of exogenous NO precursor or donor could mimic the hyperalgesic effect of endogenous NO. Intradermal injection of either the NOS substrate L-arginine or the NO donor 3-(4-morphinolinyl)-sydnonimine hydrochloride (SIN-1) produced hyperalgesia. However, this hyperalgesia differed from PGE2-induced hyperalgesia, because it was independent of the cAMP second messenger system and blocked by the guanylyl cyclase inhibitor ODQ. Therefore, although exogenous NO induces hyperalgesia, it acts by a mechanism different from that by which endogenous NO facilitates PGE2-induced hyperalgesia. Consistent with the hypothesis that these mechanisms are distinct, we found that inhibition of PGE2-induced hyperalgesia caused by L-NMA could be reversed by a low dose of the NO donor SIN-1. The following facts suggest that this dose of SIN-1 mimics a permissive effect of basal levels of NO with regard to PGE2-induced hyperalgesia: (1) this dose of SIN-1 does not produce hyperalgesia when administered alone, and (2) the effect was not blocked by ODQ. In conclusion, we have shown that low levels of NO facilitate cAMP-dependent PGE2-induced hyperalgesia, whereas higher levels of NO produce a cGMP-dependent hyperalgesia." @default.
• W1954733039 created "2016-06-24" @default.
• W1954733039 creator A5037181353 @default.
• W1954733039 creator A5037505930 @default.
• W1954733039 creator A5044040014 @default.
• W1954733039 date "1998-09-01" @default.
• W1954733039 modified "2023-10-17" @default.
• W1954733039 title "Nitric Oxide Signaling in Pain and Nociceptor Sensitization in the Rat" @default.
• W1954733039 cites W1603878868 @default.
• W1954733039 cites W1656820092 @default.
• W1954733039 cites W1821594443 @default.
• W1954733039 cites W1969887614 @default.
• W1954733039 cites W1971406932 @default.
• W1954733039 cites W1976798000 @default.
• W1954733039 cites W1978939719 @default.
• W1954733039 cites W1980358253 @default.
• W1954733039 cites W1982081911 @default.
• W1954733039 cites W1983587864 @default.
• W1954733039 cites W1986793505 @default.
• W1954733039 cites W1991142272 @default.
• W1954733039 cites W1992700615 @default.
• W1954733039 cites W1996590529 @default.
• W1954733039 cites W2000298019 @default.
• W1954733039 cites W2001982896 @default.
• W1954733039 cites W2004061912 @default.
• W1954733039 cites W2006537284 @default.
• W1954733039 cites W2006612548 @default.
• W1954733039 cites W2013040468 @default.
• W1954733039 cites W2013947622 @default.
• W1954733039 cites W2016534769 @default.
• W1954733039 cites W2016715406 @default.
• W1954733039 cites W2020841267 @default.
• W1954733039 cites W2032494329 @default.
• W1954733039 cites W2048187420 @default.
• W1954733039 cites W2055435244 @default.
• W1954733039 cites W2059588207 @default.
• W1954733039 cites W2062100071 @default.
• W1954733039 cites W2062931550 @default.
• W1954733039 cites W2065750772 @default.
• W1954733039 cites W2067654199 @default.
• W1954733039 cites W2075542527 @default.
• W1954733039 cites W2080994974 @default.
• W1954733039 cites W2081883648 @default.
• W1954733039 cites W2084741333 @default.
• W1954733039 cites W2108999152 @default.
• W1954733039 cites W2124939272 @default.
• W1954733039 cites W2133984838 @default.
• W1954733039 cites W2163945685 @default.
• W1954733039 cites W2249851544 @default.
• W1954733039 cites W2286481087 @default.
• W1954733039 cites W2401756962 @default.
• W1954733039 cites W2411409629 @default.
• W1954733039 cites W2413232269 @default.
• W1954733039 cites W2416870836 @default.
• W1954733039 cites W4244655143 @default.
• W1954733039 doi "https://doi.org/10.1523/jneurosci.18-17-07008.1998" @default.
• W1954733039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6792985" @default.
• W1954733039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9712669" @default.
• W1954733039 hasPublicationYear "1998" @default.
• W1954733039 type Work @default.
• W1954733039 sameAs 1954733039 @default.
• W1954733039 citedByCount "251" @default.
• W1954733039 countsByYear W19547330392012 @default.
• W1954733039 countsByYear W19547330392013 @default.
• W1954733039 countsByYear W19547330392014 @default.
• W1954733039 countsByYear W19547330392015 @default.
• W1954733039 countsByYear W19547330392016 @default.
• W1954733039 countsByYear W19547330392017 @default.
• W1954733039 countsByYear W19547330392018 @default.
• W1954733039 countsByYear W19547330392019 @default.
• W1954733039 countsByYear W19547330392020 @default.
• W1954733039 countsByYear W19547330392021 @default.
• W1954733039 countsByYear W19547330392022 @default.
• W1954733039 countsByYear W19547330392023 @default.
• W1954733039 crossrefType "journal-article" @default.
• W1954733039 hasAuthorship W1954733039A5037181353 @default.
• W1954733039 hasAuthorship W1954733039A5037505930 @default.
• W1954733039 hasAuthorship W1954733039A5044040014 @default.
• W1954733039 hasBestOaLocation W19547330391 @default.
• W1954733039 hasConcept C134018914 @default.
• W1954733039 hasConcept C15490471 @default.
• W1954733039 hasConcept C169760540 @default.
• W1954733039 hasConcept C170493617 @default.
• W1954733039 hasConcept C173803235 @default.
• W1954733039 hasConcept C178790620 @default.
• W1954733039 hasConcept C185592680 @default.
• W1954733039 hasConcept C202751555 @default.
• W1954733039 hasConcept C2776281502 @default.
• W1954733039 hasConcept C2777622882 @default.
• W1954733039 hasConcept C2777956040 @default.
• W1954733039 hasConcept C2778827303 @default.
• W1954733039 hasConcept C2779178603 @default.
• W1954733039 hasConcept C2779245659 @default.
• W1954733039 hasConcept C2779276759 @default.
• W1954733039 hasConcept C519581460 @default.
• W1954733039 hasConcept C55493867 @default.
• W1954733039 hasConcept C62478195 @default.
• W1954733039 hasConcept C71924100 @default.

• next